Literature DB >> 19027728

HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non-endogenous internal standard.

Scott Blackwell1, Denis St J O'Reilly, Dinesh K Talwar.   

Abstract

BACKGROUND: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthesis which has been implicated in the endothelial dysfunction. Methods for ADMA measurement often yield widely differing results, and few methods simultaneously offer satisfactory accuracy and precision. We describe a fully validated HPLC method for analysis of arginine and its methylated derivatives in human plasma using a novel internal standard.
METHODS: Arginine and related metabolites are extracted from plasma by solid phase extraction (SPE), derivatised with ortho-phthaldialdehyde and separated by isocratic reverse phase chromatography. Monoethylarginine (MEA), which is not endogenously present in human plasma was used as internal standard. SPE and chromatographic procedures are optimised and recovery, precision, linearity and sensitivity of the assay established. The suitability and performance of MEA is compared with that of monomethylarginine (MMA), the internal standard most commonly used in HPLC methods.
RESULTS: SPE yields high and reproducible recoveries (>90%). The analytes of interest are chromatographically well resolved. The method has high sensitivity (LOD, 0.01 micromol/L for arginine and 0.001 micromol/L for ADMA, SDMA and homoarginine) and good precision (CV, 2.5% for ADMA). The data obtained with the internal standards MEA and MMA is comparable in terms of assay precision and population reference intervals.
CONCLUSIONS: We describe an optimised isocratic HPLC method for the simultaneous measurement of arginine and related metabolites in plasma which exhibits satisfactory precision and is suitable for routine use. Its main advantage over other published HPLC methods is the use of the novel internal standard, MEA, which unlike other commonly used internal standards is not inherent in human plasma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027728     DOI: 10.1016/j.cca.2008.10.032

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

Review 1.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

2.  Packed red blood cells are an abundant and proximate potential source of nitric oxide synthase inhibition.

Authors:  Charles F Zwemer; Robertson D Davenport; Juan Gomez-Espina; Elisa Blanco-Gonzalez; Steven E Whitesall; Louis G D'Alecy
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

3.  Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration.

Authors:  Matthew S Alkaitis; Glenn Nardone; Jessica H Chertow; Hans C Ackerman
Journal:  Biomed Chromatogr       Date:  2015-07-30       Impact factor: 1.902

Review 4.  Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic Diseases.

Authors:  Mustafa E Sitar
Journal:  Biomark Insights       Date:  2016-12-07

5.  Association of arginase I or nitric oxide-related factors with job strain in healthy workers.

Authors:  Keiki Ogino; Tatsuo Ito; Eri Eguchi; Kenjiro Nagaoka
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

6.  Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease.

Authors:  Keith Gillis; Kathryn K Stevens; Elizabeth Bell; Rajan K Patel; Alan G Jardine; Scott T W Morris; Markus P Schneider; Christian Delles; Patrick B Mark
Journal:  Clin Kidney J       Date:  2018-02-06

7.  Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man.

Authors:  Jeremy P Langrish; Jon Unosson; Jenny Bosson; Stefan Barath; Ala Muala; Scott Blackwell; Stefan Söderberg; Jamshid Pourazar; Ian L Megson; Andrew Treweeke; Thomas Sandström; David E Newby; Anders Blomberg; Nicholas L Mills
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

8.  Regulation of nitric oxide generation by up-regulated arginase I in rat spinal cord injury.

Authors:  Takashi Imagama; Keiki Ogino; Kei Takemoto; Yoshihiko Kato; Hideo Kataoka; Hidenori Suzuki; Zhang Ran; Heri Setiawan; Yoshihisa Fujikura; Toshihiko Taguchi
Journal:  J Clin Biochem Nutr       Date:  2012-02-18       Impact factor: 3.114

9.  Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA.

Authors:  Jente Boelaert; Eva Schepers; Griet Glorieux; Sunny Eloot; Raymond Vanholder; Frédéric Lynen
Journal:  Toxins (Basel)       Date:  2016-05-13       Impact factor: 4.546

10.  Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD.

Authors:  Anne Marie Voigt Schou-Pedersen; Jens Lykkesfeldt
Journal:  J Anal Methods Chem       Date:  2018-02-01       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.